The immunoreceptor tyrosine-based activation motif of Epstein-Barr virus LMP2A is essential for blocking BCR-mediated signal transduction

Virology

Volumn 235, Issue 2, 1997, Pages 241-251

  Fruehling, Sara ^a   Longnecker, Richard ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS RECEPTOR;

ARTICLE; B LYMPHOCYTE; CONTROLLED STUDY; EPSTEIN BARR VIRUS; HUMAN; HUMAN CELL; IMMUNOBLOTTING; IN VITRO STUDY; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

HUMAN HERPESVIRUS 4;

EID: 0030754766     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.1997.8690     Document Type: Article

References (65)

1. Ambinder R. F., Mann R. B. Detection and characterization of Epstein-Barr virus in clinical specimens. Am. J. Pathol. 145:1994;239-252.
2. Bolen J. B. Nonreceptor tyrosine protein kinases. Oncogene. 8:1993;2025-2031.
3. Burkhardt A. L., Bolen J. B., Kieff E., Longnecker R. An Epstein-Barr virus transformation-associated membrane protein interacts with src family tyrosine kinases. J. Virol. 66:1992;5161-5167.
4. Busson P., Edwards R. H., Tursz T., Raab-Traub N. Sequence polymorphism in the Epstein-Barr virus latent membrane protein (LMP)-2 gene. J. Gen. Virol. 76:1995;139-145.
5. Cambier J. C. New nomenclature for the Reth motif (or ARH1/TAM/ARAM/YXXL). Immunol. Today. 16:1995;110.
6. Cambier J. C., Pleiman C. M., Clark M. R. Signal transduction by the B cell antigen receptor and its coreceptors. Annu. Rev. Immunol. 12:1994;457-486.
7. Chen F., Zou J. Z., di Renzo L., Winberg G., Hu L. F., Klein E., Klein G., Ernberg I. A subpopulation of normal B cells latently infected with Epstein-Barr virus resembles Burkitt lymphoma cells in expressing EBNA-1 but not EBNA-2 or LMP1. J. Virol. 69:1995;3752-3758.
8. Chen H. I., Sudol M. The WW domain of Yes-associated protein binds a proline-rich ligand that differs from the consensus established for Src homology 3-binding modules. Proc. Natl. Acad. Sci. USA. 92:1995;7819-7823.
9. Cheng A. M., Rowley B., Pao W., Hayday A., Bolen J. B., Pawson T. Syk tyrosine kinase required for mouse viability and B-cell development. Nature. 378:1995;303-306.
10. Cohen J. I., Wang F., Mannick J., Kieff E. Epstein-Barr virus nuclear protein 2 is a key determinant of lymphocyte transformation. Proc. Natl. Acad. Sci. USA. 86:1989;9558-9562.
11. DeFranco A. L. Transmembrane signaling by antigen receptors of B and T lymphocytes. Curr. Opin. Cell Biol. 7:1995;163-175.
12. Farrell P. J. Epstein-Barr virus immortalizing genes. Trends Microbiol. 3:1995;105-109.
13. Flaswinkel H., Reth M. Dual role of the tyrosine activation motif of the Ig-alpha protein during signal transduction via the B cell antigen receptor. EMBO J. 13:1994;83-89.
14. Franken M., Annis B., Ali A. N., Wang F. 5′ coding and regulatory region sequence divergence with conserved function of the Epstein-Barr virus LMP2A homolog in herpesvirus papio. J. Virol. 69:1995;8011-8019.
15. Frech B., Zimber-Strobl U., Suentzenich K. O., Pavlish O., Lenoir G. M., Bornkamm G. W., Mueller-Lantzsch N. Identification of Epstein-Barr virus terminal protein 1 (TP1) in extracts of four lymphoid cell lines, expression in insect cells, and detection of antibodies in human sera. J. Virol. 64:1990;2759-2767.
16. Fruehling S., Lee S., Herrold R., Frech B., Laux G., Kremmer E., Grässer F. A., Longnecker R. Identification of latent membrane protein 2A (LMP2A) domains essential for the LMP2A dominant-negative effect on B-lymphocyte surface immunoglobulin signal transduction. J. Virol. 70:1996;6216-6226.
17. Gold M. R., Matsuuchi L. Signal transduction by the antigen receptors of B and T lymphocytes. Int. Rev. Cytol. 157:1995;181-276.
18. Gratama J. W., Oosterveer M. A., Lepoutre J., Fibbe W. E., Ringden O., Vossen J. M., Willemze R., Bolhuis R. L., van Rood J. J., Ernberg I. Epstein-Barr virus infection in allogeneic marrow grafting: Lessons for transplant physicians and virologists. Ann. Hematol. 64:1992;A162-165.
19. Gratama J. W., Oosterveer M. A., Lepoutre J., van Rood J. J., Zwaan F. E., Vossen J. M., Kapsenberg J. G., Klein G., Ernberg I. Persistence and transfer of Epstein-Barr virus after allogeneic bone marrow transplantation. Transplant. Proc. 21:1989;3097-3098.
20. Hammerschmidt W., Sugden B. Genetic analysis of immortalizing functions of Epstein-Barr virus in human B lymphocytes. Nature. 340:1989;393-397.
21. Heston L., Rabson M., Brown N., Miller G. New Epstein-Barr virus variants from cellular subclones of P3J-HR-1 Burkitt lymphoma. Nature. 295:1982;160-163.
22. Hibbs M. L., Tarlinton D. M., Armes J., Grail D., Hodson G., Maglitto R., Stacker S. A., Dunn A. R. Multiple defects in the immune system of lyn-deficient mice, culminating in autoimmune disease. Cell. 83:1995;301-311.
23. Irving B. A., Chan A. C., Weiss A. Functional characterization of a signal transducing motif present in the T cell antigen receptor zeta chain. J. Exp. Med. 177:1993;1093-1103.
24. Iwashima M., Irving B. A., van O. N., Chan A. C., Weiss A. Sequential interactions of the TCR with two distinct cytoplasmic tyrosine kinases. Science. 263:1994;1136-1139.
25. Kaye K. M., Izumi K. M., Kieff E. Epstein-Barr virus latent membrane protein 1 is essential for B-lymphocyte growth transformation. Proc. Natl. Acad. Sci. USA. 90:1993;9150-9154.
26. Kieff E. Epstein-Barr virus and its replication. Fundamental Virology. 1996;Raven Press, New York. p. 1109-1162.
27. Kimura T., Sakamoto H., Appella E., Siraganian R. P. Conformational changes induced in the protein tyrosine kinase p72syk by tyrosine phosphorylation or by binding of phosphorylated immunoreceptor tyrosine-based activation motif peptides. Mol. Cell. Biol. 16:1996;1471-1478.
28. Lee S. K., Stern P. H. Studies on the mechanism of desensitization of the parathyroid hormone-stimulated calcium signal in UMR-106 cells: Reversal of desensitization by alkaline phosphatase but not by protein kinase C downregulation. J. Bone Miner. Res. 9:1994;781-789.
29. Longnecker R., Druker B., Roberts T. M., Kieff E. An Epstein-Barr virus protein associated with cell growth transformation interacts with a tyrosine kinase. J. Virol. 65:1991;3681-3692.
30. Longnecker R., Kieff E. A second Epstein-Barr virus membrane protein (LMP2) is expressed in latent infection and colocalizes with LMP1. J. Virol. 64:1990;2319-2326.
31. Longnecker R., Miller C. L., Miao X.-Q., Marchini A., Kieff E. The only domain which distinguishes Epstein-Barr virus latent membrane 2A (LMP2A) from LMP2B is dispensible for lymphocyte infection and growth transformation in vitro, and LMP2A is therefore nonessential. J. Virol. 66:1992;6461-6469.
32. Longnecker R., Miller C. L., Miao X.-Q., Tomkinson B., Kieff E. The last seven transmembrane and carboxy terminal tail of Epstein-Barr virus latent membrane 2 (LMP2) are dispensible for lymphocyte infection and growth transformation. J. Virol. 67:1993a;2006-2013.
33. Longnecker R., Miller C. L., Tomkinson B., Miao X. Q., Kieff E. Deletion of DNA encoding the first five transmembrane domains of Epstein-Barr virus latent membrane proteins 2A and 2B. J. Virol. 67:1993b;5068-5074.
34. Mann K., Staunton D., Thorley-Lawson D. A. An Epstein-Barr virus-encoded protein found in plasma membranes of transformed cells. J. Virol. 55:1985;233-237.
35. Marchini A., Tomkinson B., Cohen J. I., Kieff E. BHRF1, the Epstein-Barr virus gene with homology to Bcl2, is dispensible for B-lymphocyte transformation and virus replication. J. Virol. 65:1991;5991-6000.
36. Menezes J., Leibold W., Klein G., Clements G. Establishment and characterization of an Epstein-Barr virus (EBV)- negative lymphoblastoid B cell line (BJA-B) from an exceptional, EBV-genome-negative African Burkitt's lymphoma. Biomedicine. 22:1975;276-284.
37. 2+. Biochem. J. 269:1990;513-519.
38. Miller C. L., Burkhardt A. L., Lee J. H., Stealey B., Longnecker R., Bolen J. B., Kieff E. Integral membrane protein 2 of Epstein-Barr virus regulates reactivation from latency through dominant negative effects on protein-tyrosine kinases. Immunity. 2:1995;155-166.
39. Miller C. L., Lee J. H., Kieff E., Longnecker R. An integral membrane protein (LMP2) blocks reactivation of Epstein-Barr virus from latency following surface immunoglobulin crosslinking. Proc. Natl. Acad. Sci. USA. 91:1994;772-776.
40. Miller C. L., Longnecker R., Kieff E. Epstein-Barr virus latent membrane protein 2A blocks calcium mobilization in B lymphocytes. J. Virol. 67:1993;3087-3094.
41. Miller G. The Epstein-Barr virus. Fields B. N., Knipe D. M. Virology. 1990;563-589 Raven Press, New York.
42. Miyashita E. M., Yang B., Lam K. M. C., Crawford D. H., Thorley-Lawson D. A. A novel form of Epstein-Barr virus latency in normal B cells in vivo. Cell. 80:1995;593-601.
43. Nishizumi H., Taniuchi I., Yamanashi Y., Kitamura D., Ilic D., Mori S., Watanabe T., Yamamoto T. Impaired proliferation of peripheral B cells and indication of autoimmune disease in lyn-deficient mice. Immunity. 3:1995;549-560.
44. Pawson T., Gish G. D. SH2 and SH3 domains: From structure to function. Cell. 71:1992;359-362.
45. Qu L., Rowe D. Epstein-Barr virus latent gene expression in uncultured peripheral blood lymphocytes. J. Virol. 66:1992;3715-3724.
46. Reth M. Antigen receptor tail clue. Nature. 338:1989;383-384.
47. Romeo C., Amiot M., Seed B. Sequence requirements for induction of cytolysis by the T cell antigen/Fc receptor zeta chain. Cell. 68:1992;889-897.
48. Rowe D. T., Hall L., Joab I., Laux G. Identification of the Epstein-Barr virus terminal protein gene products in latently infected lymphocytes. J. Virol. 64:1990;2866-2875.
49. Schaffhausen B. SH2 domain structure and function. Biochim. Biophys. Acta. 1242:1995;61-75.
50. Songyang Z., Shoelson S. E., Chaudhuri M., Gish G., Pawson T., Haser W. G., King F., Roberts T., Ratnofsky S., Lechleider R. J., Neel B. G., Birge R. B., Fajardo J. E., Chou M. M., Hanafusa H., Schaffhausen B., Cantley L. C. SH2 domains recognize specific phosphopeptide sequences. Cell. 72:1993;767-778.
51. Songyang Z., Shoelson S. E., McGlade J., Olivier P., Pawson T., Bustelo X. R., Barbacid M., Sabe H., Hanafusa H., Yi T., Ren R., Baltimore D., Ratinofsky S., Feldman R. A., Cantley L. C. Specific motifs recognized by the SH2 domains of Csk, 3BP2, fps/fes, GRB-2, HCP, SHC, Syk, and Vav. Mol. Cell. Biol. 14:1994;2777-2785.
52. Straus S. E., Cohen J. I., Tosato G., Meier J. NIH conference. Epstein-Barr virus infections: Biology, pathogenesis, and management. Ann. Int. Med. 118:1993;45-58.
53. Sudol M., Bork P., Einbond A., Kastury K., Druck T., Negrini M., Hueber K., Lehman D. Characterization of the mammalian YAP (Yes-associated protein) gene and its role in defining a novel protein module, the WW domain. J. Biol. Chem. 270:1995;14733-14741.
54. Swaminathan S., Tomkinson B., Kieff E. Recombinant Epstein-Barr virus with small RNA (EBER) genes deleted transforms lymphocytes and replicates in vitro. Proc. Natl. Acad. Sci. USA. 88:1991;1546-1550.
55. 2+. EMBO J. 13:1994;1341-1349.
56. Thorley-Lawson D. A., Miyashita E. M., Khan G. Epstein-Barr virus and the B cell: That's all it takes. Trends Microbiol. 4:1996;204-208.
57. Tierney R. J., Steven N., Young L. S., Rickinson A. B. Epstein-Barr virus latency in blood mononuclear cells: Analysis of viral gene transcription during primary infection and in the carrier state. J. Virol. 68:1994;7374-7385.
58. Tomkinson B., Kieff E. Use of second-site homologous recombination to demonstrate that Epstein-Barr virus nuclear protein 3B is not important for lymphocyte infection or growth transformation in vitro. J. Virol. 66:1992;2893-2903.
59. Tomkinson B., Robertson E., Kieff E. Epstein-Barr virus nuclear proteins EBNA-3A and EBNA-3B are essential for B lymphocyte growth transformation. J. Virol. 67:1993;2014-2025.
60. Turner M., Mee P. J., Costello P. S., Williams O., Price A. A., Duddy L. P., Furlong M. T., Geahlen R. L., Tybulewicz V. L. J. Perinatal lethality and blocked B-cell development in mice lacking the tyrosine kinase Syk. Nature. 378:1995;298-302.
61. Wang D., Liebowitz D., Kieff E. An EBV membrane protein expressed in immortalized lymphocytes transforms established rodent cells. Cell. 43:1985;831-840.
62. Wange R. L., Malek S. N., Desiderio S., Samelson L. E. Tandem SH2 domains of ZAP-70 bind to T cell antigen receptor zeta and CD3 epsilon from activated Jurkat T cells. J. Biol. Chem. 268:1993;19797-19801.
63. Weiss A., Littman D. R. Signal transduction by lymphocyte antigen receptors. Cell. 76:1994;263-274.
64. Yates J. L., Warren N., Sugden B. Stable replication of plasmids derived from Epstein-Barr virus in various mammalian cells. Nature. 313:1985;812-815.
65. Young L. S., Lau R., Rowe M., Niedobitek G., Packham G., Shanahan F., Rowe D. T., Greenspan D., Greenspan J. S., Rickinson A. B., Farrell P. J. Differentiation-associated expression of the Epstein-Barr virus BZLF1 transactivator protein in oral hairy leukoplakia. J. Virol. 65:1991;2868-2874.